Cubist Systematic Strategies, LLC Heron Therapeutics, Inc. Transaction History

Cubist Systematic Strategies, LLC

$15.8 Billion
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$1.71 - $3.06 $4,548 - $8,139	2,660 Added 4.96%	56,282 $155,000
Q4 2023 Feb 14, 2024	BUY	$0.54 - $1.82 $28,955 - $97,592	53,622 New	53,622 $91,000
Q2 2023 Aug 14, 2023	BUY	$1.11 - $2.88 $8,902 - $23,097	8,020 Added 29.44%	35,258 $40,000
Q1 2023 May 15, 2023	SELL	$1.51 - $3.25 $488,096 - $1.05 Million	-323,243 Reduced 92.23%	27,238 $41,000
Q4 2022 Feb 14, 2023	SELL	$2.25 - $4.67 $34,411 - $71,422	-15,294 Reduced 4.18%	350,481 $876,000
Q3 2022 Nov 14, 2022	BUY	$2.66 - $5.37 $859,113 - $1.73 Million	322,975 Added 754.61%	365,775 $1.54 Million
Q2 2022 Aug 15, 2022	SELL	$2.3 - $6.29 $161,453 - $441,539	-70,197 Reduced 62.12%	42,800 $119,000
Q1 2022 May 16, 2022	SELL	$4.63 - $9.94 $20,529 - $44,073	-4,434 Reduced 3.78%	112,997 $646,000
Q4 2021 Feb 14, 2022	BUY	$8.35 - $12.6 $252,888 - $381,603	30,286 Added 34.75%	117,431 $1.07 Million
Q3 2021 Nov 15, 2021	BUY	$10.13 - $15.0 $507,928 - $752,115	50,141 Added 135.5%	87,145 $932,000
Q2 2021 Aug 16, 2021	SELL	$13.27 - $18.48 $10,815 - $15,061	-815 Reduced 2.16%	37,004 $574,000
Q1 2021 May 17, 2021	BUY	$14.49 - $20.72 $427,121 - $610,763	29,477 Added 353.36%	37,819 $613,000
Q4 2020 Feb 16, 2021	SELL	$14.61 - $22.14 $62,340 - $94,471	-4,267 Reduced 33.84%	8,342 $177,000
Q3 2020 Nov 16, 2020	SELL	$13.67 - $17.77 $43,634 - $56,721	-3,192 Reduced 20.2%	12,609 $187,000
Q2 2020 Aug 14, 2020	SELL	$10.89 - $21.47 $1.62 Million - $3.2 Million	-149,058 Reduced 90.42%	15,801 $232,000
Q1 2020 May 15, 2020	BUY	$10.23 - $24.56 $581,984 - $1.4 Million	56,890 Added 52.69%	164,859 $1.94 Million
Q4 2019 Feb 14, 2020	BUY	$17.42 - $26.61 $1.88 Million - $2.87 Million	107,969 New	107,969 $2.54 Million
Q2 2019 Aug 14, 2019	SELL	$16.93 - $26.22 $246,602 - $381,920	-14,566 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$23.15 - $28.34 $337,202 - $412,800	14,566 New	14,566 $356,000
Q4 2018 Feb 14, 2019	SELL	$22.03 - $32.01 $235,500 - $342,186	-10,690 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$30.0 - $40.85 $203,970 - $277,739	6,799 Added 174.74%	10,690 $338,000
Q2 2018 Aug 14, 2018	BUY	$26.4 - $42.0 $102,722 - $163,422	3,891 New	3,891 $151,000
Q1 2018 May 15, 2018	SELL	$18.43 - $28.8 $320,589 - $500,976	-17,395 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$14.8 - $18.85 $257,446 - $327,895	17,395	17,395 $315,000

Others Institutions Holding HRTX

# of Institutions

179

Shares Held

121M

Call Options Held

80.4K

Put Options Held

94.9K

Rubric Capital Management LP New York, NY

26.7M
Shares

$41.4 Million
1.48% of portfolio
Adage Capital Partners Gp, L.L.C. Boston, MA

8.85M
Shares

$13.7 Million
0.03% of portfolio
Vanguard Group Inc Valley Forge, PA

8.72M
Shares

$13.5 Million
0.0% of portfolio
Black Rock Inc. New York, NY

8.33M
Shares

$12.9 Million
0.0% of portfolio
Velan Capital Investment Management LP Alpharetta, GA

6.99M
Shares

$10.8 Million
28.8% of portfolio

View Full List

About HERON THERAPEUTICS, INC.

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $184M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

More about HRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account